Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending Men Who Have Sex with Men — Five Cities, United States, 2017 | MMWR

Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending Men Who Have Sex with Men — Five Cities, United States, 2017 | MMWR

MMWR Surveillance Summaries (No. 2) PDF of this issue

Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending Men Who Have Sex with Men — Five Cities, United States, 2017

Weekly / April 12, 2019 / 68(14);321–325

Michelle L. Johnson Jones, MPH1; Johanna Chapin-Bardales, PhD2; Destani Bizune, MPH3; John R. Papp, PhD1; Christi Phillips1; Robert D. Kirkcaldy, MD1; Cyprian Wejnert, PhD2; Kyle T. Bernstein, PhD1; National HIV Behavioral Surveillance Sexually Transmitted Infection Study Group (View author affiliations)

Summary

What is already known about this topic?

Men who have sex with men (MSM) are disproportionately affected by sexually transmitted diseases (STDs) and human immunodeficiency virus (HIV) infection. Most MSM STD prevalence data are from STD and HIV clinic attendees.

What is added by this report?

Among community venue–attending MSM in five cities in 2017, approximately one in eight had an extragenital chlamydial or gonococcal infection. Rectal gonorrhea prevalence was higher in MSM infected with HIV than in those not infected with HIV.

What are the implications for public health practice?

Sexually active MSM should be screened at least annually for chlamydia and gonorrhea at all exposed anatomic sites; some MSM might benefit from more frequent screening.